Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

BRIEF-Hls Therapeutics Announces Update On Health Canada Filings For Mycare And Trinomia

Published 2020-12-16, 06:35 a/m
© Reuters.

Dec 16 (Reuters) - HLS Therapeutics Inc HLS.TO :

* HLS THERAPEUTICS ANNOUNCES UPDATE ON HEALTH CANADA FILINGS FOR MYCARE AND TRINOMIA

* HLS THERAPEUTICS INC - HEALTH CANADA APPROVES MYCARE PSYCHIATRY LAB ASSAYS FOR USE IN DIAGNOSTIC LAB SETTINGS

* HLS THERAPEUTICS INC - HEALTH CANADA ISSUED A NOTICE OF DEFICIENCY FOR TRINOMIA

* HLS THERAPEUTICS INC - MYCARE INSITE POINT-OF-CARE (POC) DEVICE IS UNDER REVIEW AND COULD BE APPROVED IN H1-2021

* HLS THERAPEUTICS - WILL BE WORKING CLOSELY WITH LICENSOR OF TRINOMIA PRODUCT TO ASSESS PATHWAY REQUIRED TO ADDRESS DEFICIENCY NOTED BY HEALTH CANADA

* HLS THERAPEUTICS - PENDING SUBMISSION FOR TRINOMIA MAY REQUIRE ADDITIONAL SCIENTIFIC INFORMATION ON SAFETY AND EFFICACY TO SUPPORT APPROVAL OF APPLICATION

* HLS THERAPEUTICS INC - HEALTH CANADA NOTED THERE IS ON-GOING STUDY USING TRINOMIA

* HLS THERAPEUTICS INC - IN INTERIM, FOCUS OF CARDIOVASCULAR FRANCHISE WILL REMAIN FIRMLY ON SUCCESS OF VASCEPA IN CANADA

* HLS THERAPEUTICS INC - HEALTH CANADA NOTED THAT "…A REGULATORY DECISION FOR TRINOMIA SHOULD AWAIT THESE STUDY RESULTS."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.